Patents by Inventor Albert Andrzej Jaxa-Chamiec

Albert Andrzej Jaxa-Chamiec has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gadd45beta targeting agents
    Patent number: 9518083
    Abstract: Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders.
    Type: Grant
    Filed: February 10, 2015
    Date of Patent: December 13, 2016
    Assignee: Imperial Innovations Limited
    Inventors: Guido Franzoso, Albert Andrzej Jaxa-Chamiec, Caroline Minli Rachel Low, Simona Maria Monti, Menotti Ruvo, Laura Tornatore, Catherine Jane Tralau-Stewart
  • GADD45BETA TARGETING AGENTS
    Publication number: 20150368294
    Abstract: Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders.
    Type: Application
    Filed: February 10, 2015
    Publication date: December 24, 2015
    Inventors: Guido Franzoso, Albert Andrzej Jaxa-Chamiec, Caroline Minli Rachel Low, Simona Maria Monti, Menotti Ruvo, Laura Tornatore, Catherine Jane Tralau-Stewart
  • Gadd45beta targeting agents
    Patent number: 8993717
    Abstract: Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: March 31, 2015
    Assignee: Imperial Innovations Limited
    Inventors: Guido Franzoso, Albert Andrzej Jaxa-Chamiec, Caroline Minli Rachel Low, Simona Maria Monti, Menotti Ruvo, Laura Tornatore, Catherine Jane Tralau-Stewart
  • GADD45BETA TARGETING AGENTS
    Publication number: 20120277164
    Abstract: Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders.
    Type: Application
    Filed: October 22, 2010
    Publication date: November 1, 2012
    Applicant: Imperial Innovations Limited
    Inventors: Guido Franzoso, Albert Andrzej Jaxa-Chamiec, Caroline Minli Rachel Low, Simona Maria Monti, Menotti Ruvo, Laura Tornatore, Catherine Jane Tralau-Stewart
  • GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS
    Publication number: 20120004273
    Abstract: Disclosed herein are compounds of formula (I) and: wherein: X is Ar—C(O)CH(R20)— or Ar1—NHC(O)CH2—; and Ar is: naphthyl optionally substituted with one or more groups Y; pyridyl optionally substituted with one or more groups Z; or the group Ar1 etc, these compounds being useful for treating neurological diseases such as schizophrenia, dementia or attention deficit disorder.
    Type: Application
    Filed: January 30, 2008
    Publication date: January 5, 2012
    Inventors: Nadia Mamoona Ahmad, Clive Leslie Branch, Albert Andrzej Jaxa-Chamiec, Justine Yeun Quai Lai, David John Nash
  • GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS
    Publication number: 20100048656
    Abstract: Compounds of formula (I) or a salt thereof are provided: wherein R6, R7, R8, R9, X, Ar, n, and m are as defined in the description. Uses of the compounds as medicaments, and in the manufacture of medicament for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder are also disclosed. The invention further discloses pharmaceutical compositions and combinations comprising the compounds.
    Type: Application
    Filed: January 30, 2008
    Publication date: February 25, 2010
    Inventors: Nadia Mamoona Ahmad, Daniele Andreotti, Albert Andrzej Jaxa-Chamiec, Justine Yeun Quai Lai
  • GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric Disorders
    Publication number: 20100016399
    Abstract: Compounds of formula (I) or a salt thereof are provided: wherein R1, R2, R3, R4, R5, R6, R7, R8, R21 and m are as defined in the description. Uses of the compounds as medicaments, and in the manufacture of medicament for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder are also disclosed. The invention further discloses pharmaceutical compositions and combinations comprising the compounds.
    Type: Application
    Filed: January 30, 2008
    Publication date: January 21, 2010
    Inventors: Nadia Mamoona Ahmad, Albert Andrzej Jaxa-Chamiec, Justine Yeun Quai Lai, Roderich Alan Porter
  • Glycine Transport Inhibitors
    Publication number: 20080287547
    Abstract: The present invention relates to compounds of formula (I), or to salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof.
    Type: Application
    Filed: December 21, 2005
    Publication date: November 20, 2008
    Inventors: Daniel Marcus Bradley, Clive Leslie Branch, Wai Ngor Chan, Steven Coulton, Martin Leonard Gilpin, Andrew Jonathan Harris, Albert Andrzej Jaxa-Chamiec, Justine Yeun Quai Lai, Jacqueline Anne Macritchie, Howard Robert Marshall, David John Nash, Roderick Alan Porter, Simone Spada, Kevin Michael Thewlis, Simon Edward Ward